CoChat
Sign Up
Cited by 59

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Circadian disruption and cancer- and treatment-related symptoms

Amidi, Ali, Wu, Lisa M.·2022·Frontiers in Oncology
DOI 10.3389/fonc.2022.1009064
Open this paper in CoChat — free account

Abstract

Cancer patients experience a number of co-occurring side- and late-effects due to cancer and its treatment including fatigue, sleep difficulties, depressive symptoms, and cognitive impairment. These symptoms can impair quality of life and may persist long after treatment completion. Furthermore, they may exacerbate each other’s intensity and development over time. The co-occurrence and interdependent nature of these symptoms suggests a possible shared underlying mechanism. Thus far, hypothesized mechanisms that have been purported to underlie these symptoms include disruptions to the immune and endocrine systems. Recently circadian rhythm disruption has emerged as a related pathophysiological mechanism underlying cancer- and cancer-treatment related symptoms. Circadian rhythms are endogenous biobehavioral cycles lasting approximately 24 hours in humans and generated by the circadian master clock – the hypothalamic suprachiasmatic nucleus. The suprachiasmatic nucleus orchestrates rhythmicity in a wide range of bodily functions including hormone levels, body temperature, immune response, and rest-activity behaviors. In this review, we describe four common approaches to the measurement of circadian rhythms, highlight key research findings on the presence of circadian disruption in cancer patients, and provide a review of the literature on associations between circadian rhythm disruption and cancer- and treatment-related symptoms. Implications for future research and interventions will be discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fonc.2022.1009064

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 225

  1. Christensen, 2009, Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer, Breast Cancer Res Treat, 113, 10.1007/s10549-008-9920-9 · DOI
  2. Janelsins, 2014, Prevalence, mechanisms, and management of cancer-related cognitive impairment, Int Rev Psychiatry, 26, 10.3109/09540261.2013.864260 · DOI
  3. Cleeland, 2003, Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? a cytokine-immunologic model of cancer symptoms, Cancer, 97, 10.1002/cncr.11382 · DOI
  4. Schmidt, 2012, Fatigue and quality of life in breast cancer survivors: Temporal courses and long-term pattern, J Cancer Surviv., 6, 10.1007/s11764-011-0197-3 · DOI
  5. Calvio, 2010, Measures of cognitive function and work in occupationally active breast cancer survivors, J Occup. Environ Med, 52, 10.1097/JOM.0b013e3181d0bef7 · DOI
  6. Liu, 2009, Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy, Psychooncology., 18, 10.1002/pon.1412 · DOI
  7. Van Onselen, 2013, Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery, Breast, 22, 10.1016/j.breast.2012.07.007 · DOI
  8. Lange, 2014, Baseline cognitive functions among elderly patients with localised breast cancer, Eur J Cancer, 50, 10.1016/j.ejca.2014.05.026 · DOI
  9. Amidi, 2015, Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients, Psychooncology., 24, 10.1002/pon.3804 · DOI
  10. Doong, 2015, Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery, Biol Res Nurs., 17, 10.1177/1099800414550394 · DOI
  11. Ancoli-Israel, 2014, Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: A 1-year longitudinal study, Support. Care Cancer, 22, 10.1007/s00520-014-2204-5 · DOI
  12. Sanford, 2014, Prospective longitudinal evaluation of a symptom cluster in breast cancer, J Pain Symptom Manage, 47, 10.1016/j.jpainsymman.2013.05.010 · DOI
  13. Hsu, 2017, Symptom cluster trajectories during chemotherapy in breast cancer outpatients, J Pain Symptom Manage, 53, 10.1016/j.jpainsymman.2016.12.354 · DOI
  14. Colagiuri, 2011, Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery, J Pain Symptom Manage, 42, 10.1016/j.jpainsymman.2011.02.012 · DOI
  15. Koppelmans, 2012, Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy, J Clin Oncol, 30, 10.1200/JCO.2011.37.0189 · DOI
  16. Suppli, 2014, Increased risk for depression after breast cancer: A nationwide population-based cohort study of associated factors in denmark 1998-2011, J Clin Oncol, 32, 10.1200/JCO.2013.54.0419 · DOI
  17. Amidi, 2015, Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment, Support. Care Cancer, 23, 10.1007/s00520-015-2663-3 · DOI
  18. Wu, 2016, Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study, Soc Sci Med, 156, 10.1016/j.socscimed.2016.03.016 · DOI
  19. Nguyen, 2011, A literature review of symptom clusters in patients with breast cancer, Expert Rev Pharmacoecon. Outcomes Res, 11, 10.1586/erp.11.55 · DOI
  20. Kim, 2012, Common biological pathways underlying the psychoneurological symptom cluster in cancer patients, Cancer Nurs., 35, E1, 10.1097/NCC.0b013e318233a811 · DOI
  21. Miaskowski, 2004, Symptom clusters: The new frontier in symptom management research, J Natl Cancer Inst Monogr, 2004, 17, 10.1093/jncimonographs/lgh023 · DOI
  22. Bower, 2011, Inflammation and behavioral symptoms after breast cancer treatment: Do fatigue, depression, and sleep disturbance share a common underlying mechanism, J Clin Oncol, 29, 10.1200/JCO.2011.36.1154 · DOI
  23. Miller, 2008, Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer, J Clin Oncol, 26, 10.1200/JCO.2007.10.7805 · DOI
  24. Dantzer, 2009, Cytokine, sickness behavior, and depression, Immunol Allergy Clin North Am, 29, 10.1016/j.iac.2009.02.002 · DOI · Paper page
  25. Rich, 2008, Analyzing the symptoms in cancer patients, IEEE Eng. Med Biol Mag., 27, 10.1109/MEMB.2007.907364 · DOI
  26. Shattuck, 2016, Towards an integrative picture of human sickness behavior, Brain. Behav Immun, 57, 10.1016/j.bbi.2016.05.002 · DOI
  27. Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 10.1016/j.cell.2010.01.025 · DOI · Paper page
  28. Lippitz, 2013, Cytokine patterns in patients with cancer: A systematic review, Lancet Oncol, 14, 10.1016/S1470-2045(12)70582-X · DOI
  29. McKelvey, 2018, Radiation, inflammation and the immune response in cancer, Mamm. Genome, 29, 10.1007/s00335-018-9777-0 · DOI
  30. Edwardson, 2019, “Chemotherapy and inflammatory cytokine signalling in cancer cells and the tumour microenvironment,”, 173
  31. Bower, 2005, Diurnal cortisol rhythm and fatigue in breast cancer survivors, Psychoneuroendocrinology, 30, 92, 10.1016/j.psyneuen.2004.06.003 · DOI · Paper page
  32. Oh, 2019, Altered hypothalamus-Pituitary-Adrenal axis function: A potential underlying biological pathway for multiple concurrent symptoms in patients with advanced lung cancer, Psychosom. Med, 81, 41, 10.1097/PSY.0000000000000648 · DOI
  33. Weinrib, 2010, Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer, Cancer, 116, 10.1002/cncr.25299 · DOI
  34. Russell, 2019, The human stress response, Nat Rev Endocrinol, 15, 10.1038/s41574-019-0228-0 · DOI · Paper page
  35. Rich, 2007, Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis, J Support. Oncol, 5
  36. Payne, 2011, Altered circadian rhythms and cancer-related fatigue outcomes, Integr Cancer Ther, 10, 10.1177/1534735410392581 · DOI
  37. Porter, 2012, Circadian disruption–a new direction for psycho-oncology research, Ann Behav Med, 44, 1, 10.1007/s12160-012-9376-3 · DOI
  38. Innominato, 2014, The circadian timing system in clinical oncology, Ann Med, 46, 191, 10.3109/07853890.2014.916990 · DOI
  39. Dibner, 2010, The mammalian circadian timing system: Organization and coordination of central and peripheral clocks, Annu Rev Physiol, 72, 10.1146/annurev-physiol-021909-135821 · DOI · Paper page
  40. Videnovic, 2014, The clocks that time us’-circadian rhythms in neurodegenerative disorders, Nat Rev Neurol, 10, 10.1038/nrneurol.2014.206 · DOI
  41. Franken, 2009, Circadian clock genes and sleep homeostasis, Eur J Neurosci, 29, 10.1111/j.1460-9568.2009.06723.x · DOI
  42. Yu, 2014, Circadian factor BMAL1 in histaminergic neurons regulates sleep architecture, Curr Biol, 24, 10.1016/j.cub.2014.10.019 · DOI
  43. Mang, 2016, Altered sleep homeostasis in rev-erbα knockout mice, Sleep, 39, 589, 10.5665/sleep.5534 · DOI
  44. Boyce, 2010, Circadian rhythms and depression, Aust Fam. Physician, 39
  45. Kronfeld-Schor, 2012, Circadian rhythms and depression: Human psychopathology and animal models, Neuropharmacology, 62, 10.1016/j.neuropharm.2011.08.020 · DOI · Paper page
  46. Schnell, 2014, Rhythm and mood: Relationships between the circadian clock and mood-related behavior, Behav Neurosci, 128, 10.1037/a0035883 · DOI
  47. Kondratova, 2010, Circadian clock proteins control adaptation to novel environment and memory formation, Aging (Albany. NY)., 2, 10.18632/aging.100142 · DOI
  48. De Bundel, 2013, Cognitive dysfunction, elevated anxiety, and reduced cocaine response in circadian clock-deficient cryptochrome knockout mice, Front Behav Neurosci, 7, 10.3389/fnbeh.2013.00152 · DOI
  49. Habbal, 2009, Circadian rhythm and the immune response: A review, Int Rev Immunol, 28, 93, 10.1080/08830180802645050 · DOI
  50. Cermakian, 2013, Crosstalk between the circadian clock circuitry and the immune system, Chronobiol. Int, 30, 10.3109/07420528.2013.782315 · DOI · Paper page
  51. Narasimamurthy, 2012, Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines, Proc Natl Acad Sci, 109, 10.1073/pnas.1209965109 · DOI
  52. Rich, 2005, Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer, Clin Cancer Res, 11, 10.1158/1078-0432.CCR-04-2000 · DOI
  53. Leone, 2012, Role of proinflammatory cytokines on lipopolysaccharide-induced phase shifts in locomotor activity circadian rhythm, Chronobiol. Int, 29, 10.3109/07420528.2012.682681 · DOI
  54. Cavadini, 2007, TNF- suppresses the expression of clock genes by interfering with e-box-mediated transcription, Proc Natl Acad Sci, 104, 10.1073/pnas.0701466104 · DOI
  55. Gamble, 2014, Circadian clock control of endocrine factors, Nat Rev Endocrinol, 10, 10.1038/nrendo.2014.78 · DOI
  56. Ikegami, 2019, Interconnection between circadian clocks and thyroid function, Nat Rev Endocrinol, 15, 590, 10.1038/S41574-019-0237-Z · DOI · Paper page
  57. Tsang, 2016, Endocrine regulation of circadian physiology, J Endocrinol, 230, R1, 10.1530/JOE-16-0051 · DOI
  58. Liu, 2005, The relationship between fatigue and light exposure during chemotherapy, Support. Care Cancer, 13, 10.1007/s00520-005-0824-5 · DOI
  59. Irwin, 2019, Sleep and inflammation: Partners in sickness and in health, Nat Rev Immunol, 19, 10.1038/s41577-019-0190-z · DOI
  60. Irwin, 2016, Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation, Biol Psychiatry, 80, 40, 10.1016/j.biopsych.2015.05.014 · DOI · Paper page
  61. Godbout, 2007, Stress-induced immune dysregulation: Implications for wound healing, infectious disease and cancer, Artic. J Neuroimmune Pharmacol, 1, 10.1007/s11481-006-9036-0 · DOI
  62. Aldea, 2014, The role of depression and neuroimmune axis in the prognosis of cancer patients, J B.U.ON., 19, 5, 10.1016/j.mce.2020.111093 · DOI
  63. Redd, 2014, Systematic light exposure in the treatment of cancer-related fatigue: A preliminary study, Psychooncology., 23, 10.1002/pon.3553 · DOI
  64. Wu, 2018, The effect of systematic light exposure on sleep in a mixed group of fatigued cancer survivors, J Clin Sleep Med, 14, 10.5664/jcsm.6874 · DOI
  65. Denlinger, 2014, Survivorship: Fatigue, version 1.2014, J Natl Compr Canc Netw, 12, 10.6004/jnccn.2014.0082 · DOI
  66. Saligan, 2015, The biology of cancer-related fatigue: A review of the literature, Support. Care Cancer, 23, 10.1007/S00520-015-2763-0/FIGURES/2 · DOI
  67. Webster, 2003, The functional assessment of chronic illness therapy (FACIT) measurement system: Properties, applications, and interpretation, Health Qual. Life Outcomes, 1, 10.1186/1477-7525-1-79 · DOI · Paper page
  68. Stein, 2004, Further validation of the multidimensional fatigue symptom inventory-short form, J Pain Symptom Manage, 27, 14, 10.1016/j.jpainsymman.2003.06.003 · DOI · Paper page
  69. Savard, 2001, Insomnia in the context of cancer: A review of a neglected problem, J Clin Oncol, 19, 895, 10.1200/JCO.2001.19.3.895 · DOI · Paper page
  70. Beck, 2004, Psychometric evaluation of the Pittsburgh sleep quality index in cancer patients, J Pain Symptom Manage, 27, 10.1016/j.jpainsymman.2003.12.002 · DOI · Paper page
  71. Madsen, 2015, Actigraphy for measurements of sleep in relation to oncological treatment of patients with cancer: A systematic review, Sleep Med Rev, 20, 73, 10.1016/J.SMRV.2014.07.002 · DOI
  72. Marino, 2013, Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography, Sleep, 36, 10.5665/sleep.3142 · DOI · Paper page
  73. Krebber, 2014, Prevalence of depression in cancer patients: A meta-analysis of diagnostic interviews and self-report instruments, Psychooncology., 23, 10.1002/PON.3409 · DOI · Paper page
  74. Radloff, 1977, The CES-d scale: A self-report depression scale for research in the general population, Appl Psychol Meas., 1, 385, 10.1177/014662167700100306 · DOI · Paper page
  75. Lange, 2019, Cancer-related cognitive impairment: An update on state of the art, detection, and management strategies in cancer survivors, Ann Oncol Off J Eur Soc Med Oncol, 30, 10.1093/ANNONC/MDZ410 · DOI · Paper page
  76. Lange, 2020, Cognitive impairment in patients with breast cancer before surgery: Results from a CANTO cohort subgroup, Cancer Epidemiol. Biomarkers Prev, 29, 10.1158/1055-9965.EPI-20-0346 · DOI
  77. Wefel, 2011, International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer, Lancet Oncol, 12, 10.1016/S1470-2045(10)70294-1 · DOI
  78. Bray, 2018, Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment, J Cancer Surviv., 12, 10.1007/s11764-018-0692-x · DOI
  79. Jacobs, 2007, Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients, J Pain Symptom Manage, 33, 13, 10.1016/j.jpainsymman.2006.06.011 · DOI
  80. Broadbent, 1982, The cognitive failures questionnaire (CFQ) and its correlates, Br J Clin Psychol, 21, 1, 10.1111/J.2044-8260.1982.TB01421.X · DOI
  81. Hutchinson, 2012, Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review, Cancer Treat Rev, 38, 10.1016/j.ctrv.2012.05.002 · DOI
  82. Henneghan, 2021, Measuring self-reported cancer-related cognitive impairment: Recommendations from the cancer neuroscience initiative working group, J Natl Cancer Inst, 113, 10.1093/JNCI/DJAB027 · DOI
  83. Claustrat, 2005, The basic physiology and pathophysiology of melatonin, Sleep Med Rev, 9, 11, 10.1016/j.smrv.2004.08.001 · DOI
  84. Arendt, 2005, Melatonin: Characteristics, concerns, and prospects, J Biol Rhythms, 20, 291, 10.1177/0748730405277492 · DOI
  85. Middleton, 2013, “Measurement of melatonin and 6-sulphatoxymelatonin,” in, Methods Mol Biol, 1065, 10.1007/978-1-62703-616-0_11 · DOI
  86. Crowley, 2016, Estimating the dim light melatonin onset of adolescents within a 6-h sampling window: the impact of sampling rate and threshold method, Sleep Med, 20, 59, 10.1016/J.SLEEP.2015.11.019 · DOI
  87. Pandi-Perumal, 2007, Dim light melatonin onset (DLMO): A tool for the analysis of circadian phase in human sleep and chronobiological disorders, Prog Neuropsychopharmacol Biol Psychiatry, 31, 1, 10.1016/j.pnpbp.2006.06.020 · DOI
  88. Reid, 2019, Assessment of circadian rhythms, Neurol Clin, 37, 10.1016/j.ncl.2019.05.001 · DOI · Paper page
  89. Surrall, 1987, Effect of ibuprofen and indomethacin on human plasma melatonin, J Pharm Pharmacol, 39, 10.1111/J.2042-7158.1987.TB05129.X · DOI
  90. Voultsios, 1997, Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin, J Biol Rhythms, 12, 10.1177/074873049701200507 · DOI
  91. Stoschitzky, 1999, Influence of beta-blockers on melatonin release, Eur J Clin Pharmacol, 55, 10.1007/S002280050604 · DOI
  92. Härtter, 2006, Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin, Basic Clin Pharmacol Toxicol, 99, 10.1111/J.1742-7843.2006.PTO_491.X · DOI
  93. Burgess, 2015, Home circadian phase assessments with measures of compliance yield accurate dim light melatonin onsets, Sleep, 38, 10.5665/SLEEP.4734 · DOI
  94. Colletti, 2021, Nutraceutical approach to chronic osteoarthritis: From molecular research to clinical evidence, Int J Mol Sci, 22, 10.3390/IJMS222312920 · DOI
  95. Wu, 2012, Fatigue and disrupted sleep-wake patterns in patients with cancer: A shared mechanism, Clin J Oncol Nurs., 16, 10.1188/12.CJON.E56-E68 · DOI
  96. Kirschbaum, 1989, Salivary cortisol in psychobiological research: an overview, Neuropsychobiology, 22, 10.1159/000118611 · DOI · Paper page
  97. Selmaoui, 2003, Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: A study of three different 24-h cycles over six weeks, Life Sci, 73, 10.1016/J.LFS.2003.05.007 · DOI
  98. Zeitzer, 2016, Aberrant nocturnal cortisol and disease progression in women with breast cancer, Breast Cancer Res Treat, 158, 43, 10.1007/s10549-016-3864-2 · DOI
  99. Ryan, 2016, Use of salivary diurnal cortisol as an outcome measure in randomised controlled trials: A systematic review, Ann Behav Med, 50, 10.1007/S12160-015-9753-9 · DOI
  100. Fekedulegn, 2007, Area under the curve and other summary indicators of repeated waking cortisol measurements, Psychosom. Med, 69, 10.1097/PSY.0B013E31814C405C · DOI
  101. Stalder, 2016, Assessment of the cortisol awakening response: Expert consensus guidelines, Psychoneuroendocrinology, 63, 10.1016/J.PSYNEUEN.2015.10.010 · DOI · Paper page
  102. Huang, 2015, Circadian rhythms measured by actigraphy during oncological treatments: A systematic review, Biol Rhythm Res, 46, 10.1080/09291016.2015.1004840 · DOI
  103. Rogers, 2014, Impairment in circadian activity rhythms occurs during dexamethasone therapy in children with leukemia, Pediatr Blood Cancer, 61, 10.1002/pbc.25147 · DOI
  104. Liu, 2013, Fatigue and circadian activity rhythms in breast cancer patients before and after chemotherapy: A controlled study, Fatigue Biomed Heal Behav, 1, 12, 10.1080/21641846.2012.741782 · DOI
  105. Aschoff, 1983, Circadian control of body temperature, J Therm. Biol, 8, 10.1016/0306-4565(83)90094-3 · DOI · Paper page
  106. Weinert, 2007, The circadian rhythm of core temperature: Effects of physical activity and aging, Physiol Behav, 90, 10.1016/j.physbeh.2006.09.003 · DOI
  107. Weinert, 2010, Circadian temperature variation and ageing, Ageing Res Rev, 9, 51, 10.1016/j.arr.2009.07.003 · DOI
  108. Buhr, 2010, Temperature as a universal resetting cue for mammalian circadian oscillators, Sci., 330, 10.1126/science.1195262 · DOI · Paper page
  109. Kräuchi, 2007, The thermophysiological cascade leading to sleep initiation in relation to phase of entrainment, Sleep Med Rev, 11, 10.1016/j.smrv.2007.07.001 · DOI · Paper page
  110. Sarabia, 2008, Circadian rhythm of wrist temperature in normal-living subjects: A candidate of new index of the circadian system, Physiol Behav, 95, 10.1016/j.physbeh.2008.08.005 · DOI · Paper page
  111. Gonçalves, 2014, Nonparametric methods in actigraphy: An update, Sleep Sci, 7, 10.1016/J.SLSCI.2014.09.013 · DOI
  112. Marler, 2006, The sigmoidally transformed cosine curve: A mathematical model for circadian rhythms with symmetric non-sinusoidal shapes, Stat Med, 25, 10.1002/SIM.2466 · DOI
  113. Paudel, 2011, Rest/activity rhythms and cardiovascular disease in older men, Chronobiol. Int, 28, 10.3109/07420528.2011.553016 · DOI
  114. Cornelissen, 2014, Cosinor-based rhythmometry, Theor Biol Med Model, 11, 10.1186/1742-4682-11-16 · DOI
  115. Doyle, 2022, Enhancing cosinor analysis of circadian phase markers using the gamma distribution, Sleep Med, 92, 1, 10.1016/J.SLEEP.2022.01.015 · DOI
  116. Lévi, 2014, Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival, Chronobiol. Int, 31, 891, 10.3109/07420528.2014.924523 · DOI
  117. Minors, 1996, The difference between activity when in bed and out of bed. i. healthy subjects and selected patients, Chronobiol. Int, 13, 27, 10.3109/07420529609040839 · DOI
  118. Natale, 2015, The difference between in bed and out of bed activity as a behavioral marker of cancer patients: A comparative actigraphic study, Chronobiol Int, 32, 10.3109/07420528.2015.1053909 · DOI
  119. Innominato, 2009, Circadian rhythm in rest and activity: A biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer, Cancer Res, 69, 10.1158/0008-5472.CAN-08-4747 · DOI
  120. Lévi, 2020, Tele-monitoring of cancer patients’ rhythms during daily life identifies actionable determinants of circadian and sleep disruption, Cancers (Basel)., 12, 1, 10.3390/cancers12071938 · DOI
  121. Huang, 2018, Hidden Markov models for monitoring circadian rhythmicity in telemetric activity data, J R Soc Interface, 15, 10.1098/RSIF.2017.0885 · DOI
  122. Asgari-Targhi, 2019, Mathematical modeling of circadian rhythms, Wiley Interdiscip. Rev Syst Biol Med, 11, 10.1002/WSBM.1439 · DOI
  123. Slats, 2013, Reciprocal interactions between sleep, circadian rhythms and alzheimer’s disease: Focus on the role of hypocretin and melatonin, Ageing Res Rev, 12, 188, 10.1016/J.ARR.2012.04.003 · DOI
  124. Kalliolia, 2014, Plasma melatonin is reduced in huntington’s disease, Mov. Disord, 29, 10.1002/mds.26003 · DOI
  125. Bradley, 2017, Sleep and circadian rhythm disturbance in bipolar disorder, Psychol Med, 47, 10.1017/S0033291717000186 · DOI
  126. Lozano-Lorca, 2021, Salivary melatonin rhythm and prostate cancer: CAPLIFE study, J Urol., 207, 10.1097/JU.0000000000002294 · DOI
  127. Bartsch, 1981, Urinary melatonin levels in human breast cancer patients, J Neural Transm, 52, 10.1007/BF01256753 · DOI
  128. Bartsch, 1989, Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors, Cancer, 64, 10.1002/1097-0142(19890715)64:2<426::AID-CNCR2820640215>3.0.CO;2-O · DOI
  129. Payne, 2002, The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy, Oncol Nurs. Forum, 29, 10.1188/02.ONF.1334-1340 · DOI
  130. Li, 2019, Disruption of sleep, sleep-wake activity rhythm, and nocturnal melatonin production in breast cancer patients undergoing adjuvant chemotherapy: Prospective cohort study, Sleep Med, 55, 14, 10.1016/j.sleep.2018.11.022 · DOI
  131. Karasek, 2005, Serum melatonin circadian profiles in women suffering from cervical cancer, J Pineal Res, 39, 10.1111/j.1600-079X.2005.00221.x · DOI
  132. Hu, 2009, Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer, Adv Ther, 26, 10.1007/s12325-009-0068-8 · DOI
  133. Chang, 2017, Relationships of salivary cortisol and melatonin rhythms to sleep quality, emotion, and fatigue levels in patients with newly diagnosed lung cancer, Eur J Oncol Nurs., 29, 79, 10.1016/j.ejon.2017.05.008 · DOI
  134. Khoory, 1988, Plasma melatonin levels in patients suffering from colorectal carcinoma, J Pineal Res, 5, 10.1111/j.1600-079X.1988.tb00651.x · DOI
  135. Zaki, 2020, Depressive symptoms, sleep profiles and serum melatonin levels in a sample of breast cancer patients, Nat Sci Sleep, 12, 10.2147/NSS.S206768 · DOI
  136. Touitou, 1996, Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens, Br J Cancer, 74, 10.1038/bjc.1996.524 · DOI
  137. van der Pompe, 1996, Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer, Psychoneuroendocrinology, 21, 10.1016/0306-4530(96)00009-1 · DOI
  138. Abercrombie, 2004, Flattened cortisol rhythms in metastatic breast cancer patients, Psychoneuroendocrinology, 29, 10.1016/j.psyneuen.2003.11.003 · DOI
  139. Schrepf, 2013, Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability, Brain. Behav Immun, 10.1016/j.bbi.2012.07.022 · DOI
  140. Mazzoccoli, 2010, Altered time structure of neuro-endocrine-immune system function in lung cancer patients, BMC Cancer, 10, 10.1186/1471-2407-10-314 · DOI
  141. Kim, 2012, Association of worse prognosis with an aberrant diurnal cortisol rhythm in patients with advanced lung cancer, Chronobiol. Int, 29, 10.3109/07420528.2012.706767 · DOI
  142. Alexander, 2009, A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome, Eur J Cancer, 45, 10.1016/J.EJCA.2008.09.010 · DOI
  143. Castonguay, 2017, The roles of negative affect and goal adjustment capacities in breast cancer survivors: Associations with physical activity and diurnal cortisol secretion, Health Psychol, 36, 10.1037/HEA0000477 · DOI
  144. Giese-Davis, 2006, Depression and stress reactivity in metastatic breast cancer, Psychosom. Med, 68, 10.1097/01.PSY.0000238216.88515.E5 · DOI
  145. Ho, 2013, The associations between diurnal cortisol patterns, self-perceived social support, and sleep behavior in Chinese breast cancer patients, Psychoneuroendocrinology, 38, 10.1016/J.PSYNEUEN.2013.05.004 · DOI
  146. Hoyt, 2016, Sleep quality and depressive symptoms after prostate cancer: The mechanistic role of cortisol, Behav Neurosci, 130, 10.1037/BNE0000107 · DOI
  147. Hsiao, 2015, Habitual sleep-wake behaviors and lifestyle as predictors of diurnal cortisol patterns in young breast cancer survivors: a longitudinal study, Psychoneuroendocrinology, 53, 10.1016/J.PSYNEUEN.2014.12.014 · DOI
  148. Huang, 2020, Relationship between diurnal cortisol profile and sleep quality in patients with hepatocellular carcinoma, Biol Res Nurs., 22, 10.1177/1099800419881195 · DOI
  149. Jehn, 2010, Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer, Integr Cancer Ther, 9, 10.1177/1534735410370036 · DOI
  150. Kuhlman, 2017, Cortisol awakening response as a prospective risk factor for depressive symptoms in women after treatment for breast cancer, Psychosom. Med, 79, 10.1097/PSY.0000000000000499 · DOI
  151. Lutgendorf, 2008, Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients, J Clin Oncol, 26, 10.1200/JCO.2007.14.1978 · DOI
  152. Mormont, 2000, Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status, Clin Cancer Res, 6
  153. Sannes, 2013, Depressive symptoms and cortisol variability prior to surgery for suspected endometrial cancer, Psychoneuroendocrinology, 38, 10.1016/J.PSYNEUEN.2012.06.001 · DOI
  154. Schmidt, 2016, Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients, Brain. Behav Immun, 52, 98, 10.1016/J.BBI.2015.10.005 · DOI · Paper page
  155. Vedhara, 2006, Psychosocial factors associated with indices of cortisol production in women with breast cancer and controls, Psychoneuroendocrinology, 31, 299, 10.1016/J.PSYNEUEN.2005.08.006 · DOI
  156. Hsiao, 2017, A longitudinal study of diurnal cortisol patterns and associated factors in breast cancer patients from the transition stage of the end of active cancer treatment to post-treatment survivorship, Breast, 36, 96, 10.1016/J.BREAST.2017.06.016 · DOI
  157. Rumble, 2015, Circadian actigraphic rest-activity rhythms following surgery for endometrial cancer: A prospective, longitudinal study, Gynecol. Oncol, 137, 10.1016/j.ygyno.2015.04.001 · DOI
  158. Savard, 2009, Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy, Sleep, 32, 10.1093/sleep/32.9.1155 · DOI
  159. Sultan, 2017, Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles, Chronobiol. Int, 34, 10.1080/07420528.2017.1286501 · DOI
  160. Pati, 2007, Alterations of the characteristics of the circadian rest-activity rhythm of cancer in-patients, Chronobiol. Int, 24, 10.1080/07420520701800868 · DOI
  161. Berger, 2010, Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer, Oncol Nurs. Forum, 37, 10.1188/10.ONF.E359-E369 · DOI
  162. Jim, 2011, Fatigue, depression, sleep, and activity during chemotherapy: Daily and intraday variation and relationships among symptom changes, Ann Behav Med, 42, 10.1007/s12160-011-9294-9 · DOI
  163. Innominato, 2012, Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer, Int J Cancer, 131, 10.1002/ijc.27574 · DOI
  164. Ortiz-Tudela, 2014, The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy, Int J Cancer, 134, 10.1002/ijc.28587 · DOI
  165. Martin, 2021, Rest activity rhythms characteristics of breast cancer women following endocrine therapy, Sleep, 45, 10.1093/SLEEP/ZSAB248 · DOI
  166. Levin, 2005, Circadian function in patients with advanced non-small-cell lung cancer, Br J Cancer, 93, 10.1038/sj.bjc.6602859 · DOI
  167. Grutsch, 2011, The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer, BMC Cancer, 11, 10.1186/1471-2407-11-193 · DOI
  168. Chen, 2015, Relationships of circadian rhythms and physical activity with objective sleep parameters in lung cancer patients, Cancer Nurs., 38, 10.1097/NCC.0000000000000163 · DOI
  169. Chang, 2017, Changes in the sleep–wake rhythm, sleep quality, mood, and quality of life of patients receiving treatment for lung cancer: A longitudinal study, Chronobiol. Int, 34, 10.1080/07420528.2017.1293678 · DOI
  170. Roveda, 2019, Rest-activity circadian rhythm in breast cancer survivors at 5 years after the primary diagnosis, Chronobiol. Int, 36, 10.1080/07420528.2019.1621330 · DOI
  171. Milanti, 2021, Actigraphy-measured rest-activity circadian rhythm disruption in patients with advanced cancer: A scoping review, Support. Care Cancer, 1, 1, 10.1007/s00520-021-06317-3 · DOI
  172. Ancoli-Israel, 2006, Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer, Support. Care Cancer, 14, 10.1007/s00520-005-0861-0 · DOI
  173. Ancoli-Israel, 2022, Reductions in sleep quality and circadian activity rhythmicity predict longitudinal changes in objective and subjective cognitive functioning in women treated for breast cancer, Support. Care Cancer, 30, 10.1007/s00520-021-06743-3 · DOI
  174. Berger, 2010, Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy, Support. Care Cancer, 18, 10.1007/s00520-009-0636-0 · DOI
  175. Berger, 2007, Values of Sleep/Wake, Activity/Rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy, J Pain Symptom Manage, 33, 398, 10.1016/j.jpainsymman.2006.09.022 · DOI
  176. Cash, 2018, Depressive symptoms and actigraphy-measured circadian disruption predict head and neck cancer survival, Psychooncology., 27, 10.1002/pon.4862 · DOI
  177. Du-Quiton, 2010, Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer, Psychooncology., 19, 10.1002/pon.1539 · DOI
  178. Innominato, 2018, Circadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer, Cancer Med, 7, 10.1002/cam4.1711 · DOI
  179. Ma, 2014, Rest/activity rhythm is related to the coexistence of pain and sleep disturbance among advanced cancer patients with pain, Support. Care Cancer, 22, 87, 10.1007/S00520-013-1918-0 · DOI
  180. Miaskowski, 2011, Sleep-wake circadian activity rhythm parameters and fatigue in oncology patients before the initiation of radiation therapy, Cancer Nurs., 34, 10.1097/NCC.0b013e3181f65d9b · DOI
  181. Mormont, 2002, Contribution of the rest-activity circadian rhythm to quality of life in cancer patients, Chronobiol. Int, 19, 10.1081/CBI-120002606 · DOI
  182. Palesh, 2017, Relationship between subjective and actigraphy-measured sleep in 237 patients with metastatic colorectal cancer, Qual. Life Res, 26, 10.1007/s11136-017-1617-2 · DOI
  183. Roscoe, 2002, Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment, Support. Care Cancer, 10, 10.1007/s00520-001-0317-0 · DOI · Paper page
  184. Dhruva, 2012, Sleep-wake circadian activity rhythms and fatigue in family caregivers of oncology patients, Cancer Nurs., 35, 70, 10.1097/NCC.0b013e3182194a25 · DOI
  185. Carpenter, 2004, Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors, Menopause, 11, 10.1097/01.GME.0000113848.74835.1A · DOI
  186. Roche, 2014, Thoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapy, Chronobiol. Int, 31, 10.3109/07420528.2013.864301 · DOI
  187. Jung-Hynes, 2010, Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells, J Pineal Res, 49, 10.1111/J.1600-079X.2010.00767.X · DOI
  188. Mormont, 2002, Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: Relevance for clinical outcome, Anticancer Res, 22
  189. Sephton, 2000, Diurnal cortisol rhythm as a predictor of breast cancer survival, J Natl Cancer Inst, 92, 994, 10.1093/jnci/92.12.994 · DOI · Paper page
  190. Sephton, 2013, Diurnal cortisol rhythm as a predictor of lung cancer survival, Brain. Behav Immun, 30, 10.1016/j.bbi.2012.07.019 · DOI
  191. Sancar, 2021, Clocks, cancer, and chronochemotherapy, Sci ., 371, 10.1126/science.abb0738 · DOI
  192. Patel, 2021, Clock at the core of cancer development, Biol (Basel)., 10, 1, 10.3390/BIOLOGY10020150 · DOI
  193. Monk, 2010, Enhancing circadian zeitgebers, Sleep, 33, 10.1093/sleep/33.4.421 · DOI
  194. Roenneberg, 2013, Light and the human circadian clock, Handb. Exp Pharmacol, 217, 10.1007/978-3-642-25950-0_13 · DOI
  195. Pickel, 2020, Feeding rhythms and the circadian regulation of metabolism, Front Nutr, 7, 10.3389/fnut.2020.00039 · DOI
  196. Baron, 2014, Circadian misalignment and health, Int Rev Psychiatry, 26, 10.3109/09540261.2014.911149 · DOI · Paper page
  197. Ancoli-Israel, 2012, Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer, Support. Care Cancer, 20, 10.1007/s00520-011-1203-z · DOI
  198. Johnson, 2018, Bright light therapy improves cancer-related fatigue in cancer survivors: a randomized controlled trial, J Cancer Surviv., 12, 10.1007/s11764-017-0659-3 · DOI
  199. Valdimarsdottir, 2018, Programmed environmental illumination during autologous stem cell transplantation hospitalization for the treatment of multiple myeloma reduces severity of depression: A preliminary randomized controlled trial, Cancer Med, 7, 10.1002/cam4.1690 · DOI
  200. Starreveld, 2021, Light therapy for cancer-related fatigue in (Non-)Hodgkin lymphoma survivors: Results of a randomized controlled trial, Cancers 2021, 13, 10.3390/CANCERS13194948 · DOI

200 of 225 shown

Metadata

Authors
Amidi, A., & Wu, L. M.
Venue
Frontiers in Oncology
Publisher
Frontiers Media SA
Published
2022-10-28
Volume
12
ISSN
2234-943X
DOI
10.3389/fonc.2022.1009064
Cited by
59
References
27
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
  • Danish Cancer Society Research Center (R174-A11447-17-S52)
  • Danmarks Frie Forskningsfond (5053-00220B)
  • Horizon 2020 (754513)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circadian disruption and cancer- and treatment-related symptoms. https://app.cochat.ai/papers/10.3389/fonc.2022.1009064
The paper
Amidi, A., & Wu, L. M. (2022). Circadian disruption and cancer- and treatment-related symptoms. Frontiers in Oncology. https://doi.org/10.3389/fonc.2022.1009064